Literature DB >> 10908374

Mucins and inflammatory bowel disease.

T Shirazi1, R J Longman, A P Corfield, C S Probert.   

Abstract

There is a layer of mucus lining the gastrointestinal tract, which acts as both a lubricant and as a physical barrier between luminal contents and the mucosal surface. The mucins that make up this layer consist of a protein backbone with oligosaccharides attached to specific areas of the protein core. These areas are called the variable number tandem repeat regions. The degree of glycosylation of the mucins is central to their role in the mucus barrier. The oligosaccharides are variable and complex. It has been demonstrated that the degree of sulphation and sialylation and the length of the oligosaccharide chains all vary in inflammatory bowel disease. These changes can alter the function of the mucins. Mucins are broadly divided into two groups, those that are secreted and those that are membrane bound. The major mucins present in the colorectum are MUC1, MUC2, MUC3, and MUC4. Trefoils are a group of small peptides that have an important role in the mucus layer. Three trefoils have been demonstrated so far. They seem to play a part in mucosal protection and in mucosal repair. They may help to stabilise the mucus layer by cross linking with mucins to aid formation of stable gels. Trefoils can be expressed in the ulcer associated cell lineage, a glandular structure that can occur in the inflamed mucosa. There seem to be differences in the expression of trefoils in the colon and the small bowel, which may imply different method of mucosal repair.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908374      PMCID: PMC1741691          DOI: 10.1136/pmj.76.898.473

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  47 in total

1.  Histochemical and genetic analysis of colonic mucin glycoproteins in Hirschsprung's disease.

Authors:  A Aslam; R D Spicer; A P Corfield
Journal:  J Pediatr Surg       Date:  1999-02       Impact factor: 2.545

2.  South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover.

Authors:  C S Probert; B F Warren; T Perry; E H Mackay; J F Mayberry; A P Corfield
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

3.  Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor.

Authors:  J R Gum; J W Hicks; N W Toribara; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

4.  Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants.

Authors:  N Parker; H H Tsai; S D Ryder; A H Raouf; J M Rhodes
Journal:  Digestion       Date:  1995       Impact factor: 3.216

5.  Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.

Authors:  M Blank; E Klussmann; S Krüger-Krasagakes; A Schmitt-Gräff; M Stolte; G Bornhoeft; H Stein; P X Xing; I F McKenzie; C P Verstijnen
Journal:  Int J Cancer       Date:  1994-11-01       Impact factor: 7.396

6.  Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin.

Authors:  K M Tytgat; H A Büller; F J Opdam; Y S Kim; A W Einerhand; J Dekker
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

7.  Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment.

Authors:  H H Tsai; A D Dwarakanath; C A Hart; J D Milton; J M Rhodes
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

8.  Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat.

Authors:  R Chinery; R J Playford
Journal:  Clin Sci (Lond)       Date:  1995-04       Impact factor: 6.124

9.  Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.

Authors:  B J Campbell; I A Finnie; E F Hounsell; J M Rhodes
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Developmental expression of mucin genes MUC1 and MUC2.

Authors:  J A Chambers; M A Hollingsworth; A E Trezise; A Harris
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

View more
  50 in total

Review 1.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 2.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

3.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.

Authors:  Samuel K Lai; Ying-Ying Wang; Kaoru Hida; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

Review 4.  From intestinal stem cells to inflammatory bowel diseases.

Authors:  Michael Gersemann; Eduard Friedrich Stange; Jan Wehkamp
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 5.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2011-12-24       Impact factor: 15.470

Review 6.  Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.

Authors:  Joannie M Allaire; Vijay Morampudi; Shauna M Crowley; Martin Stahl; Hongbing Yu; Kirandeep Bhullar; Leigh A Knodler; Brian Bressler; Kevan Jacobson; Bruce A Vallance
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-09       Impact factor: 4.052

7.  The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

Authors:  Atsushi Nishida; Cindy W Lau; Mei Zhang; Akira Andoh; Hai Ning Shi; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

8.  Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.

Authors:  Christoph Moehle; Nikolaus Ackermann; Thomas Langmann; Charalampos Aslanidis; Alexander Kel; Olga Kel-Margoulis; Anna Schmitz-Madry; Alexandra Zahn; Wolfgang Stremmel; Gerd Schmitz
Journal:  J Mol Med (Berl)       Date:  2006-10-21       Impact factor: 4.599

9.  Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.

Authors:  Yu-Chen Hou; Chia-Chou Chu; Tsui-Ling Ko; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

Review 10.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.